Literature DB >> 3944469

Factors affecting cell growth and monoclonal antibody production in stirred reactors.

S Reuveny, D Velez, J D Macmillan, L Miller.   

Abstract

Environmental and cultural factors that could affect growth and cell viability of mouse-mouse hybridoma cells in culture were investigated. The aim was to determine conditions that could prolong viability and result in increased yields of monoclonal antibodies in stirred reactors. Factors studied included temperature, level of dissolved oxygen, nutrient depletion, and waste product accumulation. Growing cells at temperatures 3-9 degrees lower than optimum (37 degrees C) increased viability but monoclonal antibody production was lowered. A low level of dissolved oxygen (25% air saturation compared to 60% for optimum growth) prolonged cell viability and increased the monoclonal antibody yield by about 50%. Feeding cultures daily to maintain the glucose level above 1 mg/ml and at the same time feeding cells glutamine (150 micrograms/10(6) cells per day) maintained the level of viable cells at 1.7 X 10(6)/ml for at least 9 days and resulted in an antibody yield of 290 micrograms/ml, about a 70% increase over cultures fed either glucose or glutamine alone. Ammonium ion, added to cell populations at levels produced in cultures, stopped cell growth and decreased antibody production. Another waste product, lactic acid, had no toxic effect when added to media at levels found in cultures. These results agree with our suggestion that monoclonal antibody production is enhanced by maintaining cell viability over a prolonged period and provide a base for investigating modes of hybridoma cell propagation in fermentors.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3944469     DOI: 10.1016/0022-1759(86)90264-4

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  48 in total

1.  Concurrent binding to multiple ligands: kinetic rates of CD16b for membrane-bound IgG1 and IgG2.

Authors:  T E Williams; P Selvaraj; C Zhu
Journal:  Biophys J       Date:  2000-10       Impact factor: 4.033

2.  Industrial production of monoclonal antibodies and therapeutic proteins by dialysis fermentation.

Authors:  M J Comer; M J Kearns; J Wahl; M Munster; T Lorenz; B Szperalski; S Koch; U Behrendt; H Brunner
Journal:  Cytotechnology       Date:  1990-05       Impact factor: 2.058

3.  A comparison of simple growth vessels and a specially designed bioreactor for the cultivation of hybridoma cells.

Authors:  B Persson; C Emborg
Journal:  Cytotechnology       Date:  1992       Impact factor: 2.058

4.  Avoiding rapid growth at high cell densities: a potentially important optimisation criterion for hybridoma cultures.

Authors:  L K Nielsen; W Niloperbowo; S Reid; P F Greenfield
Journal:  Cytotechnology       Date:  1992       Impact factor: 2.058

5.  Influence of inoculum age on hybridoma culture kinetics.

Authors:  A Martial; M Dardenne; J M Engasser; A Marc
Journal:  Cytotechnology       Date:  1991-02       Impact factor: 2.058

6.  Growth study of lactate and ammonia double-resistant clones of HL-60 cells.

Authors:  B Schumpp; E J Schlaeger
Journal:  Cytotechnology       Date:  1992       Impact factor: 2.058

Review 7.  Hybridoma growth limitations: the roles of energy metabolism and ammonia production.

Authors:  M Newland; P F Greenfield; S Reid
Journal:  Cytotechnology       Date:  1990-05       Impact factor: 2.058

8.  The effect of Pluronic F-68 on hybridoma cells in continuous culture.

Authors:  M al-Rubeai; A N Emery; S Chalder
Journal:  Appl Microbiol Biotechnol       Date:  1992-04       Impact factor: 4.813

Review 9.  Nutrient optimization for high density biological production applications.

Authors:  D W Jayme
Journal:  Cytotechnology       Date:  1991-01       Impact factor: 2.058

10.  Adaptation of hybridoma cells to higher ammonia concentration.

Authors:  M Matsumura; M Shimoda; T Arii; H Kataoka
Journal:  Cytotechnology       Date:  1991-10       Impact factor: 2.058

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.